Using Misoprostol to Prevent Postpartum Hemorrhage in Homebirths in Pakistan
Author Information
Author(s): Mobeen N, Durocher J, Zuberi NF, Jahan N, Blum J, Wasim S, Walraven G, Hatcher J
Primary Institution: Aga Khan University
Hypothesis
Is misoprostol safe and effective in preventing postpartum hemorrhage when administered by trained traditional birth attendants at home deliveries?
Conclusion
Misoprostol significantly reduces the rate of postpartum hemorrhage by 24% when given by trained traditional birth attendants during home deliveries.
Supporting Evidence
- Misoprostol reduced the rate of postpartum hemorrhage from 21.9% to 16.5%.
- Women receiving misoprostol had significantly fewer drops in hemoglobin levels compared to those receiving placebo.
- There were no maternal deaths reported during the trial.
- Shivering and chills were more common in the misoprostol group.
Takeaway
Giving a medicine called misoprostol after a baby is born can help stop too much bleeding for moms who have their babies at home.
Methodology
A double-blind, placebo-controlled trial where women were randomized to receive either misoprostol or placebo after delivery.
Potential Biases
Potential recall bias regarding adverse effects as data were collected days after delivery.
Limitations
The study's outcomes may not be generalizable to all rural settings, and initial blood loss measurements were invalid due to monitoring difficulties.
Participant Demographics
Women giving birth at home in rural Pakistan, primarily with no formal education.
Statistical Information
P-Value
0.043
Confidence Interval
95% CI 0.59–0.97
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website